We are live on ! Find out more
FCI

Financial Counselors Inc Portfolio holdings

AUM $72.7M
1-Year Est. Return 22.36%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+22.36%
3 Year Est. Return
+77.12%
5 Year Est. Return
+99.57%
10 Year Est. Return
AUM
$6.75B
AUM Growth
+$537M
Cap. Flow
+$140M
Cap. Flow %
2.08%
Top 10 Hldgs %
25.93%
Holding
603
New
44
Increased
262
Reduced
229
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 20.16%
2 Financials 10.09%
3 Healthcare 9.42%
4 Industrials 8.71%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STZ icon
176
Constellation Brands
STZ
$22.5B
$6.27M 0.09%
24,344
+233
+1% +$57.8K
GE icon
177
GE Aerospace
GE
$382B
$6.26M 0.09%
33,203
-262
-0.8% -$44.4K
MPWR icon
178
Monolithic Power Systems
MPWR
$68.7B
$6.24M 0.09%
6,753
-2,023
-23% -$1.75M
SHOP icon
179
Shopify
SHOP
$196B
$6.15M 0.09%
76,726
-9,968
-11% -$688K
LECO icon
180
Lincoln Electric
LECO
$15.5B
$6.01M 0.09%
31,290
+5,274
+20% +$1.01M
VTV icon
181
Vanguard Morningstar Value ETF
VTV
$192B
$6M 0.09%
34,396
+1,267
+4% +$212K
GSK icon
182
GSK
GSK
$102B
$5.93M 0.09%
145,175
-3,055
-2% -$125K
ABT icon
183
Abbott
ABT
$189B
$5.92M 0.09%
51,903
-172
-0.3% -$18.9K
CVS icon
184
CVS Health
CVS
$120B
$5.71M 0.08%
90,846
+221
+0.2% +$12.9K
ASML icon
185
ASML
ASML
$685B
$5.52M 0.08%
6,622
+38
+0.6% +$34K
DFAC icon
186
Dimensional US Core Equity 2 ETF
DFAC
$49.5B
$5.45M 0.08%
158,902
-398
-0.2% -$13.1K
MSCI icon
187
MSCI
MSCI
$40.8B
$5.39M 0.08%
9,241
+55
+0.6% +$29.8K
INTC icon
188
Intel
INTC
$490B
$5.32M 0.08%
226,765
-9,870
-4% -$246K
MA icon
189
Mastercard
MA
$495B
$5.29M 0.08%
10,716
+640
+6% +$298K
XLV icon
190
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$5.25M 0.08%
34,081
+192
+0.6% +$29.1K
CRL icon
191
Charles River Laboratories
CRL
$13.3B
$5.24M 0.08%
26,592
+4,896
+23% +$1.02M
IDEV icon
192
iShares Core MSCI International Developed Markets ETF
IDEV
$32.5B
$5.21M 0.08%
73,509
ORCL icon
193
Oracle
ORCL
$418B
$5.2M 0.08%
30,534
+3,843
+14% +$557K
PAYX icon
194
Paychex
PAYX
$43.2B
$5.19M 0.08%
38,676
+2,839
+8% +$360K
XLI icon
195
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$5.18M 0.08%
38,270
+54
+0.1% +$6.86K
QQQ icon
196
Invesco QQQ Trust
QQQ
$478B
$5.03M 0.07%
10,300
+410
+4% +$194K
SPYM
197
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$4.95M 0.07%
73,391
-75
-0.1% -$4.88K
IP icon
198
International Paper
IP
$22.1B
$4.93M 0.07%
100,949
+616
+0.6% +$28.7K
UMBF icon
199
UMB Financial
UMBF
$11.3B
$4.88M 0.07%
46,422
-400
-0.9% -$39K
SPSM icon
200
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
$4.82M 0.07%
106,001
+1,599
+2% +$70.2K

Similar funds

Financial Counselors Inc's Q3 2024 Portfolio in Review

As of Q3 2024, Financial Counselors Inc held 603 positions worth $6.75B, up 8.6% from $6.22B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Financial Counselors Inc's Q3 2024 filing shows 44 new, 262 increased, 229 reduced and 17 closed positions. Its largest new stake was Labcorp: 57,555 shares worth $12.9M. The largest sale was Schwab Short-Term US Treasury ETF, an estimated $9.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Financial Counselors Inc's largest Q3 2024 buy was Labcorp: 57,555 shares worth $12.9M.
  • Financial Counselors Inc added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $11M increase.
  • Financial Counselors Inc's biggest Q3 2024 reduction was Schwab Short-Term US Treasury ETF, cutting an estimated $9.9M.
  • Financial Counselors Inc fully exited West Pharmaceutical in Q3 2024, selling an estimated $3.89M.
  • Financial Counselors Inc's ten largest holdings make up 26% of its $6.75B portfolio in Q3 2024.
  • Financial Counselors Inc opened 44 new positions and closed 17 in Q3 2024.
  • Financial Counselors Inc's portfolio value rose 8.6% quarter-over-quarter to $6.75B.

Based on Financial Counselors Inc's 13F filing for Q3 2024, filed 14 Nov 2024.